A new traffic pattern is coming to a busy intersection—one that will not only improve safety but also help first responders.
A new traffic pattern is coming to a busy intersection—one that will not only improve safety but also help first responders.
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company’s lead product candidate includes IFx2.0, ...
Medscape UK : Get the latest medical news, drug alerts, expert commentary, clinical guidelines, and practice of medicine coverage for UK healthcare professionals.
When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology to develop a cure.